Press Releases

Jun 29, 2016
BeiGene Announces Initiation of a Combination Trial of the BTK Inhibitor BGB-3111 with the PD-1 Antibody BGB-A317    read more...
Jun 06, 2016
BeiGene to Participate in Goldman Sachs 37th Annual Global Healthcare Conference    read more...
Jun 05, 2016
BeiGene Presents Initial Clinical Data on PD-1 Antibody BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting    read more...
May 19, 2016
BeiGene Announces Presentation on BGB-A317 at the 2016 American Society of Clinical Oncology Annual Meeting    read more...
May 11, 2016
BeiGene Reports First Quarter 2016 Financial Results    read more...
May 04, 2016
BeiGene Appoints Dr. Ji Li as Executive Vice President, Global Head of Business Development    read more...
Apr 17, 2016
BeiGene Presents Clinical Data for RAF Dimer Inhibitor BGB-283 at the 2016 American Association for Cancer Research Annual Meeting    read more...
Apr 11, 2016
BeiGene Appoints Eric Hedrick, M.D. as Interim Chief Medical Officer    read more...
Feb 08, 2016
BeiGene Announces Closing of Its Initial Public Offering    read more...